Synthesis and dopamine receptor modulating activity of 3-substituted γ-lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide

Journal of Medicinal Chemistry

Volumn 46, Issue 5, 2003, Pages 727-733

  Dolbeare, Kristine ^a   Pontoriero, Giuseppe F ^b   Gupta, Suresh K ^b   Mishra, Ram K ^b   Johnson, Rodney L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL DERIVATIVE; DOPAMINE RECEPTOR; GAMMA LACTAM DERIVATIVE; PROLYLLEUCYLGLYCINAMIDE; PROLYLLEUCYLGLYCINAMIDE DERIVATIVE; PROPYLNORAPOMORPHINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROPHOBICITY; NONHUMAN;

ANIMALS; CATTLE; CORPUS STRIATUM; DOPAMINE AGENTS; LACTAMS; MOLECULAR CONFORMATION; MOLECULAR MIMICRY; MSH RELEASE-INHIBITING HORMONE; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037468419     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020441o     Document Type: Article

References (27)

1. Mishra, R. K.; Chiu, P.; Mishra, C. P. Pharmacology of L-Prolyl-L-Leucyl-Glycinamide (PLG): A Review. Methods Find. Exp. Clin. Pharmacol. 1983, 5, 203-233.
2. Kostrzewa, R. M.; Kastin, A. J.; Sobrain, S. K. Potentiation of Apomorphine Action in Rats by L-Prolyl-L-leucyl-glycinamide. Pharmacol. Biochem. Behav. 1978, 9, 375-378.
3. Chiu, S.; Paulose, C. S.; Mishra, R. K. Effects of L-Prolyl-L-leucyl-glycinamide (PLG) on Neuoleptic-induced Catalepsy and Dopamine/Neuroleptic Receptor Bindings. Peptides 1981, 2, 105-111.
4. Chiu, S.; Paulose, C. S.; Mishra, R. K. Neuroleptic Drug-induced Dopamine Receptor Supersensitivity: Antagonism by L-Prolyl-L-leucyl glycinamide. Science 1981, 214, 1261-1262.
5. Smith, J. R.; Morgan, M. The Effects of PLG on Drug Induced Rotation in Rats. Gen. Pharmacol. 1982, 13, 203-207.
6. 2 Receptor: Evidence for Modulation of Agonist Affinity States in Bovine Striatal Membranes. J. Neurochem. 1988, 50, 960-968.
7. Bhargava, H. N. Effects of Prolyl-leucyl-glycinamide and Cyclo-(leucyl-glycine) on the Supersensitivity of Dopamine Receptors in the Brain Induced by Chronic Administration of Haloperidol to Rats. Neuropharmacology 1984, 23, 439-444.
8. 2 Analogues Possessing Cyclic Amino Acid Residues at the C-Terminal Position. J. Med. Chem. 1986, 29, 2100-2104.
9. 2 Analogues Modified at the Prolyl Residue and Evaluation of Their Effects on the Receptor Binding Activity of the Central Dopamine Receptor Agonist, ADTN. J. Med. Chem. 1986, 29, 2104-2107.
10. 2 Modified at the Leucyl Residue. J. Med. Chem. 1990, 33, 1828-1832.
11. 2. J. Med. Chem. 1988, 31, 1430-1436.
12. 2. J. Med. Chem. 1993, 36, 256-263.
13. 2. J. Med. Chem. 1993, 36, 2356-2361.
14. 2. J. Med. Chem. 1993, 36, 3481-3483.
15. Baures, P. W.; Ojala, W. H.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Design, Synthesis, X-ray Analysis, and Dopamine Receptor-Modulating Activity of Mimics of the "C5" Hydrogen-Bonded Conformation in the Peptidomimetic 2-Oxo-3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-1-pyrrolidineacetamide. J. Med. Chem. 1994, 37, 3677-3683.
16. Khalil, E. M.; Ojala, W. H.; Pradhan, A.; Nair, V. D.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Design, Synthesis, and Dopamine Receptor Modulating Activity of Spiro Bicyclic Peptidomimetics of L-Prolyl-L-leucyl-glycinamide. J. Med. Chem. 1999, 42, 628-637.
17. 2 Receptor by L-Pro-L-Leu-Glycinamide (PLG) Analogue 3(R)-(N-L-Prolylamino)-2-oxo-1-pyrrolidineacetamide. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 1990, 14, 821-827.
18. Mishra, R. K.; Makeman, M. H.; Costain, W. J.; Nair, V. D.; Johnson, R. L. Modulation of Agonist Stimulated Adenylyl Cyclase and GTPase Activity by L-Pro-L-Leu-Glycinamide and Its Peptidomimetic Analogue in Rat Striatal Membranes. Neurosci. Lett. 1999, 261, 21-24.
19. Ungerstedt, U. Postsynaptic Supersensitivity After 6-Hydroxydopamine Induced Degeneration of the Nigro-striatal Dopamine System. Acta Physiol. Scand. 1971, 367 Suppl., 69-93.
20. Ott, M. C.; Mishra, R. K.; Johnson, R. L. Modulation of Dopaminergic Neurotransmission in the 6-Hydroxydopamine Lesioned Rotational Model by Peptidomimetic Analogues of L-Prolyl-L-leucyl-glycinamide. Brain. Res. 1996, 737, 287-291.
21. 2 (PLG). Peptides 1997, 18, 1209-1217.
22. 2 (PLG, MIF-I). Peptides 1998, 19, 403-406.
23. Ott, M. C.; Costain, W. J.; Mishra, R. K.; Johnson, R. L. L-Prolyl-L-leucyl-glycinamide and its Peptidomimetic Analogue 3(R)-[(S)-Pyrrolidinylcarbonyl]amino]-2-oxo-1-pyrrolidineacetamide (PAO-PA) Attenuate Haloperidol-Induced c-fos Expression in the Striatum. Peptides 2000, 21, 301-308.
24. Smith, A. B., III; Guzman, M. C.; Sprengeler, P. A.; Keenan, T. P.; Holocomb, R. C.; Wood, J. L.; Carroll, P. J.; Hirschmann, R. De Novo Design, Synthesis, and X-ray Structures of Pyrrolinone-Based β-Strand Peptidomimetics. J. Am. Chem. Soc. 1994, 116, 9947-9962.
25. Khalil, E. M.; Pradhan, A.; Ojala, W. H.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Synthesis and Dopamine Receptor Modulating Activity of Substituted Bicyclic Thiazolidine Lactam Peptidomimetics of L-Prolyl-L-leucyl-glycinamide. J. Med. Chem. 1999, 42, 2977-2987.
26. Baures, P. W.; Ojala, W. H.; Costain, W. J.; Ott, M. C.; Pradhan, A.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Design, Synthesis, and Dopamine Receptor-Modulating Activity of Diketopiperazine Peptidomimetics of L-Prolyl-L-leucylglycinamide. J. Med. Chem. 1997, 40, 3594-3600.
27. Bradford, M. M. A Rapid Method and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-dye Binding. Anal. Biochem. 1976, 72, 248-254.